Ultralife Beheer
Beheer criteriumcontroles 4/4
De CEO Ultralife is Mike Manna, benoemd in Nov2022, heeft een ambtstermijn van 3.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 434.11K, bestaande uit 95.6% salaris en 4.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.17% van de aandelen van het bedrijf, ter waarde $ 168.34K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.7 jaar en 16.1 jaar.
Belangrijke informatie
Mike Manna
Algemeen directeur
US$434.1k
Totale compensatie
| Percentage CEO-salaris | 95.60% |
| Dienstverband CEO | 3.7yrs |
| Eigendom CEO | 0.2% |
| Management gemiddelde ambtstermijn | 3.7yrs |
| Gemiddelde ambtstermijn bestuur | 16.1yrs |
Recente managementupdates
Recent updates
Ultralife Corporation's (NASDAQ:ULBI) Share Price Is Still Matching Investor Opinion Despite 25% Slump
NasdaqGM:ULBI 1 Year Share Price vs Fair Value Explore Ultralife's Fair Values from the Community and select yours The...Ultralife (NASDAQ:ULBI) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Ultralife: Recharging Growth With Smart Acquisitions
Summary Ultralife's revenue has been volatile in the past decade or so, but its recent comeback seems to have more legroom to grow. Through a series of recent acquisitions, the company has diversified its revenue dependence on government contracts and obtained access to a more domestic and overseas customer base. Key financial metrics demonstrate strong cash flow and organic integration of its acquisitions, supporting a positive outlook. Intense competition in the industry and integration risk remain, but so far the results show positive impacts in sales and cash flow. In conclusion, ULBI's current price is relatively cheap for interested investors seeking exposure in this field. Read the full article on Seeking AlphaUltralife Corporation: A High-Risk Stock With Just Enough Upside To Hold
Summary Ultralife Corporation is an industrial player with a global presence, specializing in power solutions and communication systems. The company reported a nearly 10% YoY revenue decline in Q3, with contracting profit margins and significant supply chain issues. While Ultralife has a solid balance sheet and liquidity, its thin profit margins and supply chain vulnerabilities raise concerns about long-term shareholder value. Despite its fair valuation, the stock is considered a high-risk play due to weak revenue predictability and operational inefficiencies. The overall recommendation for ULBI is a "hold" rating, as growth prospects exist, but risks outweigh immediate investment opportunities. Read the full article on Seeking Alpha
Lean Productivity And Tactical Acquisitions Propel Future Growth Amid Industry Challenges
Ultralife's focus on cost reduction and productivity improvements is expected to boost net margins significantly.Should You Think About Buying Ultralife Corporation (NASDAQ:ULBI) Now?
While Ultralife Corporation ( NASDAQ:ULBI ) might not have the largest market cap around , it saw significant share...Ultralife: I Bought The Dip; Here Comes The Growth
Summary ULBI's share price fell to $7 following a cyber-attack, but has since recovered to $11.50, making a 50% return in 6 months. ULBI's growth in sales revenue is driven by its battery and energy products segment, with a focus on lithium-ion batteries and communication systems. The company's adoption of lean manufacturing techniques, margin improvement, and debt paydown have led to a significant increase in performance and future cash generation, warranting a Strong Buy recommendation with a price target of $35. Read the full article on Seeking AlphaUltralife's (NASDAQ:ULBI) Earnings Are Weaker Than They Seem
Despite announcing strong earnings, Ultralife Corporation's ( NASDAQ:ULBI ) stock was sluggish. We think that the...Ultralife Corporation Is Attractive Here
Summary Ultralife Corporation specializes in batteries for government, military, and private sectors, with a focus on communications systems. Recent growth initiatives include new product developments like EL8000 Case Systems and Thin Cell Batteries. The company has shown strong revenue growth, successful M&A track record, gross margin expansion, and stable operating expenses, making it a promising investment. Read the full article on Seeking AlphaUltralife Corporation: Ready To Surge
Summary ULBI is likely to deliver above-market returns in the next two years, with improving fundamentals and a modest valuation. They should benefit from growth in the battery market and increased military spending. Management is delivering on growth and margin improvement; EPS could double in 2024. With a strengthened balance sheet, they seem poised to start deleveraging rapidly. Read the full article on Seeking AlphaThese 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For Excitement
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...Insufficient Growth At Ultralife Corporation (NASDAQ:ULBI) Hampers Share Price
With a price-to-sales (or "P/S") ratio of 0.9x Ultralife Corporation ( NASDAQ:ULBI ) may be sending bullish signals at...Is Now An Opportune Moment To Examine Ultralife Corporation (NASDAQ:ULBI)?
While Ultralife Corporation ( NASDAQ:ULBI ) might not be the most widely known stock at the moment, it led the NASDAQGM...Ultralife (NASDAQ:ULBI) May Have Issues Allocating Its Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Ultralife (NASDAQ:ULBI) Takes On Some Risk With Its Use Of Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Ultralife (NASDAQ:ULBI) Is Carrying A Fair Bit Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Ultralife secures $7.5M communications systems contract
Ultralife (NASDAQ:ULBI) announced Thursday it has received $7.5M contract to supply its integrated system of A-320 amplifiers and A-320HVA radio vehicle mounts to a major international defense contractor for government/defense modernization program. Deliveries are expected to commence in the fourth quarter of 2022 and continue through the first half of 2023. “This contract further demonstrates our success in executing a key element of our revenue growth strategy – the broadening of our global presence with international allies by extending our core U.S. government and defense business,” said Michael D. Popielec, Ultralife’s President and Chief Executive Officer.Ultralife receives $4.6M communications systems VAA order
Ultralife (NASDAQ:ULBI) received a purchase order worth ~$4.6M for supplying its Vehicle Amplifier-Adaptors (VAA) to a global prime defense contractor. Ultralife’s VAA platform provides the soldier with an enhanced range of digital voice and data communications and operational flexibility. Shipments are expected to commence in 2022.Does Ultralife (NASDAQ:ULBI) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -US$8m |
| Dec 31 2025 | US$434k | US$415k | -US$6m |
| Sep 30 2025 | n/a | n/a | US$2m |
| Jun 30 2025 | n/a | n/a | US$3m |
| Mar 31 2025 | n/a | n/a | US$5m |
| Dec 31 2024 | US$489k | US$388k | US$6m |
| Sep 30 2024 | n/a | n/a | US$9m |
| Jun 30 2024 | n/a | n/a | US$10m |
| Mar 31 2024 | n/a | n/a | US$10m |
| Dec 31 2023 | US$779k | US$377k | US$7m |
| Sep 30 2023 | n/a | n/a | US$4m |
| Jun 30 2023 | n/a | n/a | US$3m |
| Mar 31 2023 | n/a | n/a | -US$297k |
| Dec 31 2022 | US$317k | US$241k | -US$119k |
Compensatie versus markt: De totale vergoeding ($USD 434.11K ) Mike } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 659.91K ).
Compensatie versus inkomsten: De vergoeding van Mike is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Mike Manna (56 yo)
Mr. Michael E. Manna, also known as Mike, serves as President, Chief Executive Officer & Director at Ultralife Corporation since November 22, 2022. He was President of Battery & Energy Products at Ultralif...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 3.7yrs | US$434.11k | 0.17% $ 168.3k | |
| CFO, Treasurer & Corporate Secretary | 16.7yrs | US$394.15k | 0.83% $ 803.4k | |
| President of Communication System | 13.5yrs | geen gegevens | geen gegevens | |
| SVP of Sales & Business Development | 1.5yrs | geen gegevens | geen gegevens | |
| Chief Marketing Officer | 1.5yrs | geen gegevens | geen gegevens |
Ervaren management: Het managementteam van ULBI wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 3.7yrs | US$434.11k | 0.17% $ 168.3k | |
| Chair of the Board of Directors | 19.1yrs | US$108.00k | 40.28% $ 39.1m | |
| Independent Director | 16.3yrs | US$106.20k | 0.51% $ 495.6k | |
| Independent Director | 16.1yrs | US$106.20k | 0.43% $ 413.9k | |
| Independent Director | 3.4yrs | US$106.20k | 0.046% $ 44.7k |
Ervaren bestuur: De raad van bestuur van ULBI zijn ervaren en ervaren (gemiddelde ambtstermijn van 16.1 jaar).
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/07/09 05:44 |
| Aandelenkoers aan het einde van de dag | 2026/07/09 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Ultralife Corporation wordt gevolgd door 4 analisten. 0 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Joshua Sullivan | Benchmark Company |
| Ted Kundtz | Needham & Company |
| Matthew Paul | Sidoti & Company, LLC |